antibody

Denmark’s Genmab raises a bumper $500m-plus in Nasdaq IPO

https://pharmaphorum.com/news/denmarks-genmab-raises-a-bumper-500m-plus-in-nasdaq-ipo/

Otsuka has high hopes for its ‘drug creation engine’ acquisition

https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/

Hear From Seattle Genetics at ADC 2018

https://pharmaphorum.com/partner-content/hear-from-seattle-genetics-at-adc-2018/

Exclusive Speaker Interview from Janssen for SMi’s ADC Conference 2018

https://pharmaphorum.com/partner-content/exclusive-speaker-interview-from-janssen-for-smis-adc-conference-2018/

Explore the ADC component hazards, risks and safety project elements in HPAPI

https://pharmaphorum.com/partner-content/explore-adc-component-hazards-risks-safety-project-elements-hpapi/

When science and biology combine – the outlook for ADCs in cancer drug development

https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/

Antibodies and Antibody Drug Conjugates

https://pharmaphorum.com/events/antibodies-antibody-drug-conjugates/

Pfizer presents the opening keynote at the SMi’s ADC Conference 2018

https://pharmaphorum.com/partner-content/pfizer-presents-the-opening-keynote-at-the-smis-adc-conference-2018/

Avacta hoping to disrupt antibody drug dominance

https://pharmaphorum.com/news/avacta-hoping-disrupt-antibody-dominance/

Close in 10 seconds

Pharmaphorum.com

Search